Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.624 EUR | -6.45% | -8.37% | +13.25% |
Apr. 11 | Poxel: CDC falls below the 10% threshold | CF |
Feb. 15 | Poxel S.A. Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
28.1M | - | - | - | - | - | |
114B | ||||||
104B | ||||||
22.28B | - | |||||
22.41B | - | |||||
19.07B |
- Stock Market
- Equities
- POXEL Stock
- Charts Poxel
- Sector Chart